NEW YORK – BioMérieux on Wednesday reported sales growth of 16 percent for the first half of 2020 compared to the first half of 2019.
The French diagnostics firm reported total sales of €1.48 billion ($1.75 billion) for the six-month period ended June 30, 2020, up from €1.28 billion for the first half of 2019.
For the first half of the year, its clinical applications sales were up 19 percent at €1.26 billion versus €1.06 billion for the first half of 2019. The firm's industrial applications had sales of €218.8 million, a slight increase from €218.3 million.